ABEO

Abeona Therapeutics Inc.

NASDAQHealthcareBiotechnologyUS

Rating:A

Company Profile

CEO

Vishwas Seshadri

IPO Date

1980-09-19

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

News SentimentBullish

Articles

Avg Positive

22.5%

Avg Negative

2.7%

Avg Neutral

74.8%

News Feed

Abeona Therapeutics Reports Second Quarter Financial Results

GlobeNewsWire·7/28/2021·↑ positive

Abeona Stock Gains As It Concludes Type B Meeting With FDA For MPS IIIA Gene Therapy

Benzinga·7/28/2021·↑ positive

Abeona Therapeutics Announces New MRI Data Showing Increased Brain Volume in Young Patients with Sanfilippo Syndrome Type A (MPS IIIA) After Treatment with ABO-102 Gene Therapy

ABEO Sentiment & News | Diplyzer